GD2-Oligosaccharide-sp-biotin

GD2-Oligosaccharide-sp-biotin

Catalog Number:
C003143471BIO
Mfr. No.:
OO71835
Price:
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • The structure of GD2-oligosaccharide-sp-biotin (sodium salt) comprises (GalNAcβ1,4Galβ1,4Glc) with two sialic acids linked α2,3/α2,8 to the central galactose residue (Ledeen, 2009) and biotin attached β to position 1 of the reducing glucose moiety. GD2 ganglioside is expressed at a low concentration in the central nervous system, nerves, skin melanocytes and stem cells in healthy adults. On the other hand, GD2 ganglioside is overexpressed in a number of tumors, including: neuroblastoma, melanoma, small cell lung carcinoma and brain tumors. Recently, it has been found in low concentrations on breast cancer stem cells (CSC) that possess: self-renewal properties (division without disrupting the undifferentiated state) and tumor-initiating capabilities. It has been suggested that GD2 ganglioside may be developed as an effective target antigen for CSC immunotherapy (Fleurence, 2017).

          Please contact us at for specific academic pricing.

      • Properties
        • Categories
          Ganglioside Oligosaccharides and Gangliosides
          Molecular Formula
          C65H104N10O37S·2Na
          Molecular Weight
          1,695.61 g/mol
          Note
          There is no hazardous surcharge associated with this product.
          There is no special packaging charge associated with this product.

          * For research use only. Not for human or veterinary use

      • Reference
        • Hirsch et al (2002) Easily reversible desthiobiotin binding to streptavidin, avidin, and other biotin-binding biomolecules, Analytical Biochemistry, 308(2), 343-357.
          Ledeen et al (2009), Neurobiology Meets Glycosciences, In: The Sugar Code (Ed: Gabius H. J), pp 495-516, Wiley-VCH, Weinheim.
          Fleurence et al (2017), Review Article, Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy, Journal of Immunology Research Volume 2017, 16 pages.

    Documents

    Specification

    Note: If you don't receive our verification email, do the following:

    • Confirm that you entered your email address correctly.
    • Check if the email is in your spam or junk folder.
    • Or you may contact us at .
    Copyright © Amerigo Scientific. All rights reserved.